Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020:161-162:22-41.
doi: 10.1016/j.addr.2020.07.021. Epub 2020 Aug 1.

Spatiotemporal delivery of bioactive molecules for wound healing using stimuli-responsive biomaterials

Affiliations

Spatiotemporal delivery of bioactive molecules for wound healing using stimuli-responsive biomaterials

Nuria Oliva et al. Adv Drug Deliv Rev. 2020.

Abstract

Wound repair is a fascinatingly complex process, with overlapping events in both space and time needed to pave a pathway to successful healing. This additional complexity presents challenges when developing methods for the controlled delivery of therapeutics for wound repair and tissue engineering. Unlike more traditional applications, where biomaterial-based depots increase drug solubility and stability in vivo, enhance circulation times, and improve retention in the target tissue, when aiming to modulate wound healing, there is a desire to enable localised, spatiotemporal control of multiple therapeutics. Furthermore, many therapeutics of interest in the context of wound repair are sensitive biologics (e.g. growth factors), which present unique challenges when designing biomaterial-based delivery systems. Here, we review the diverse approaches taken by the biomaterials community for creating stimuli-responsive materials that are beginning to enable spatiotemporal control over the delivery of therapeutics for applications in tissue engineering and regenerative medicine.

Keywords: Biomaterials; Controlled release; Drug delivery; Regenerative medicine; Tissue engineering.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest BDA has a pending patent application for the TrAP technology platform [US20190254958A1] described in Section 6.

Publication types

MeSH terms

LinkOut - more resources